|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 473/00 |
| (11) | Patento numeris | 1660498 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04764776.3 |
| Europos patento paraiškos padavimo data | 2004-09-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-05-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-08-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2004/009819 |
| Data | 2004-09-02 |
| (87) | Numeris | WO 2005/023811 |
| Data | 2005-03-17 |
| (30) | Numeris | Data | Šalis |
| 0320738 | 2003-09-04 | GB |
| (72) |
LAWRENCE, Ronnie, Maxwell GlaxoSmithKline, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PROCESS FOR THE PREPARATION OF (1S,4R)-CIS-4-[2-AMINO-6-CHLORO-9H-PURIN-9-YL]-2-CYCLOPENTENE-1-METHANOL |
| PROCESS FOR THE PREPARATION OF (1S,4R)-CIS-4-[2-AMINO-6-CHLORO-9H-PURIN-9-YL]-2-CYCLOPENTENE-1-METHANOL |